Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Landscape of hedge fund industry in Latin America improved as the region entered the competitive global race

Thursday, September 30, 2010

From Komfie Manalo, Opalesque Asia:

The landscape of the hedge fund industry in Latin American (LatAm) changed dramatically in the past several years as fund managers in the region have successfully entered the competitive global race to win investments, according to data provider Merlin Securities.

From being shunned by many investors because of the unstable or "boom and bust" economies in the region, Latin America is enjoying a reemergence of talent and balanced risk taking in the hedge fund sector. But Merlin was quick to warn that even with the relatively promising outlook, managers in the LatAm region must be prepared to compete in a tough global environment.

Part of the reemergence of focus in LatAm is the strong monetary policies introduced by many economies in the region which resulted to a well-capitalized banking system with healthy credit. These policies were not left unnoticed by international investors, many of whom shifted their attention to LatAm after launching due diligence processes in China and India. Many of these investors were impressed by the "Brazil story," Merlin said.

In its report, The Spectrum of Investors for Latin American Hedge Funds, Merlin revealed that direct foreign investments into the LatAm region reached an unprecedented level of $100bn by 2007. This attracted a good number of talented fund managers with varying degrees of experienc......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for